NAGE Niagen Bioscience PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: NAGE
- PE Ratio
The current P/E ratio for Niagen Bioscience stock as of Jun 30, 2025 is 80.06. This is calculated based on the TTM EPS of $0.18 and the stock price of $14.41 per share.
NAGE PE ratio history
Niagen Bioscience PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 48.23 | N/A | $5.31 | $0.11 |
| 2023 | N/A | N/A | $1.43 | -$0.07 |
| 2022 | N/A | N/A | $1.68 | -$0.24 |
| 2021 | N/A | N/A | $3.74 | -$0.4 |
| 2020 | N/A | N/A | $4.8 | -$0.33 |
| 2019 | N/A | N/A | $4.31 | -$0.56 |
| 2018 | N/A | N/A | $3.43 | -$0.61 |
| 2017 | N/A | N/A | $5.88 | -$0.26 |
| 2016 | N/A | N/A | $3.31 | -$0.08 |
| 2016 | N/A | N/A | $3.66 | -$0.08 |
| 2015 | N/A | N/A | $2.7 | -$0.15 |
| 2013 | N/A | N/A | $4.8 | -$0.12 |
| 2012 | N/A | N/A | $1.68 | -$0.39 |
| 2011 | N/A | N/A | $1.65 | -$0.36 |
| 2011 | N/A | N/A | $4.08 | -$0.12 |
Niagen Bioscience PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 38.33 | -20.53% | $6.9 | $0.18 |
| Dec 2024 | 48.23 | -86.79% | $5.31 | $0.11 |
| Sep 2024 | 365 | N/A | $3.65 | $0.01 |
| Jun 2024 | N/A | N/A | $2.73 | -$0.02 |
| Mar 2024 | N/A | N/A | $3.48 | -$0.05 |
| Dec 2023 | N/A | N/A | $1.43 | -$0.07 |
| Sep 2023 | N/A | N/A | $1.46 | -$0.09 |
| Jun 2023 | N/A | N/A | $1.57 | -$0.09 |
| Mar 2023 | N/A | N/A | $1.53 | -$0.15 |
| Dec 2022 | N/A | N/A | $1.68 | -$0.24 |
| Sep 2022 | N/A | N/A | $1.23 | -$0.28 |
| Jun 2022 | N/A | N/A | $1.67 | -$0.4 |
| Mar 2022 | N/A | N/A | $2.46 | -$0.39 |
| Dec 2021 | N/A | N/A | $3.74 | -$0.4 |
| Sep 2021 | N/A | N/A | $6.27 | -$0.43 |
NAGE Price vs fair value
NAGE average PE ratio chart
NAGE PE vs peers
NAGE's PE ratio is above its peer stock EXEL.
| Stock name | PE ratio | Market cap |
|---|---|---|
| EXEL Exelixis Inc | 19.59 | $12.02B |
| NAGE Niagen Bioscience Inc. | 80.06 | $1.14B |
| NAII Natural Alternatives International Inc | N/A | $20.27M |
| SGMO Sangamo Therapeutics Inc | N/A | $126.21M |
Frequently asked questions
What is Niagen Bioscience's PE ratio?
NAGE stock has a price to earnings ratio of 80.06 as of Jun 30, 2025.
Why is Niagen Bioscience's PE ratio so high?
NAGE's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is NAGE's PE ratio calculated (Niagen Bioscience PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 30, 2025), Niagen Bioscience's share price is $14.41. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.18. Therefore, Niagen Bioscience's price to earnings ratio for today is 80.06. PE RATIO(80.06) = STOCK PRICE($14.41) / TTM EPS($0.18)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.